Polymer-free Dual Drug-Eluting Stents Evaluated in a Porcine Model
Bin Zhang,Bo Zheng,Xingang Wang,Qiuping Shi,Jia,Yong Huo,Chunshui Pan,Jingyan Han,Ming Chen
DOI: https://doi.org/10.1186/s12872-017-0654-7
IF: 2.174
2017-01-01
BMC Cardiovascular Disorders
Abstract:Background Although drug-eluting stents have dramatically reduced the rates of restenosis and target lesion revascularization, they are associated with stent thrombosis (ST), a catastrophic event likely due to delayed endothelialization and chronic inflammation caused by the polymer and the metal scaffolds. To increase the safety and efficacy of stents, polymer-free dual drug-eluting stents (DDES) have been developed. Methods A total 160 stents (Bare-metal stents (BMS), polymer-free probucol stents (PrES), sirolimus-eluting stents (SES) and DDES) were randomly implanted in the coronary arteries of 80 pigs. 14, 28, 90 and 191 days after implantation, QCA and OCT evaluations were performed in 20 pigs respectively, and the arteries were harvested for scanning electron microscope (SEM), histomorphology, histopathology analyses and for the relative expression of CD31, CD34 and CD133 on mRNA and protein levels. Results At the 14-day time point, there were significant differences in the strut rate coverage ( p = 0.011), with greater coverage in the PrES than in the SES group (53.2%vs. 20.3%, p = 0.002). As well, there were no significant differences in the expression of CD31, CD34 and CD133 between groups in mRNA and protein level. Conclusions DDES were as safe as BMS and SES, but they did not further improve the endothelialization of the stented coronary arteries in the porcine model.